---
$id: https://graph.org.ai/products/commodity/51282909
$type: Product
source: UNSPSC
code: "51282909"
title: "Ciprofloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ciprofloxacin

**UNSPSC Code**: 51282909
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic and antitubercular agent with the molecular formula C17H18FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5E8K9I0O4U, chemically known as 86393-32-0 (hydrochloride, monohydrate) but generally known as ciprofloxacin, which bears US NIH Compound Identifier 2764. European Medicines Agency schedules Ciprofloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07470MIG. The term CIPROFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules ciprofloxacin in its Anatomical Therapeutic Chemical (ATC) Classification. CIPROFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciprofloxacin under HS 29335995 and SITC 51576. As of Q4 2014, CIPROFLOXACIN remains the US FDA Preferred Term for this commodity. Ciprofloxacin bears US NLM identifiers UMLS ID C0008809 and NCI Concept Code C375. SMILES: FC1C(N2CCNCC2)CC2N(C3CC3)CC(C(=O)C2C1)C(=O)O.

